XenMatrix AB is the first antibacterial-coated, non-crosslinked porcine dermal graft proven to inhibit the colonization of MRSA, E. coli, and other bacteria in preclinical models
It uses a combination of well-characterized antibiotics, rifampin and minocycline, to offer an unmatched level of graft protection in challenging ventral hernia repair
